Faculty profile

Paul Goodyer

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Paul Goodyer

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2015.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Focal Segmental Glomerulosclerosis Lymphocyte Mutant Genes Nephrotic Syndrome Podocyte Viral Genes Cystinosis Drug Library Screening

Latest papers

Clinical practice recommendations for the diagnosis and management of nephropathic cystinosis.
Nature reviews. Nephrology · 2026
Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease
Canadian Journal of Kidney Health and Disease · 2026
Emerging therapeutic strategies for cystinosis.
Frontiers in pediatrics · 2025 · first author

All 45 publications

Latest funding

The 12th International Podocyte Conference, May 30-June 2, 2018
CIHR · 2017 · Co-investigator
$20,000
Interactions between host and viral genes in the pathogenesis of nephrotic syndrome
CIHR · 2015 · Nominated PI
Novel Therapies for Cystinosis
CIHR · 2014 · Nominated PI
$224,998

All 6 grants and awards

45 publications.

Clinical practice recommendations for the diagnosis and management of nephropathic cystinosis.

Hohenfellner K, Wühl E, Haffner D, Cystinosis Guideline Group, Koch V, Bishop R, Alhasan K, Awan A, Bacchetta J, Pozza SB, Biswas S, Bos M, Bürger F, Choi M, Elenberg E, Erler J, Froschauer S, Grimm PC, Hebestreit H, Herzig N, Inhestern L, Köppl C, Levtchenko E, Lipkin G, Muth T, Pape L, Priglinger C, Quitmann J, Reuner G, Rohayem J, Schilling B, Servais A, Soliman NA, Sollacher A, Sproedt C, Topaloglu R, Tönshoff B, Trauner D, Witt S, Goodyer P, Thoene J, Emma F

Nature reviews. Nephrology2026

DOI: 10.1038/s41581-026-01089-7 PMID: 42298212

Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease

Lanktree MB, Ashawasega N, Bevilacqua M, Bichet DG, Bollée G, Brown P-A, Girard L, Goodyer P, Hingwala J, Lemaire M

Canadian Journal of Kidney Health and Disease2026

DOI: 10.1177/20543581261455635

Emerging therapeutic strategies for cystinosis.

Goodyer P, Torban E

Frontiers in pediatrics2025First author

DOI: 10.3389/fped.2025.1601409 PMID: 40469087

Bridging pediatric and adult IgAN: challenges in applying proteinuria-driven recommendations in the new IPNA guidelines.

Cambier A, Dossier C, Lapeyraque AL, Phan V, Laroche C, Abukasm K, Benoit G, Roy JP, Hogan J, Boyer O, Monteiro R, Licht C, Goodyer P, Downie M, Bouts A, Boutaba M, Ulinski T, Troyanov S, Haas M

Pediatric nephrology (Berlin, Germany)2025

DOI: 10.1007/s00467-024-06648-3 PMID: 39779508

X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline

Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, de Beur SMJ, Florenzano P, Abu Alrob H, Aldabagh R

Journal of Clinical Endocrinology and Metabolism (JCEM)202528 citations

DOI: 10.1210/clinem/dgaf093

X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline

Khan AA, Ali DS, Appelman-Dijkstra NM, Carpenter TO, Chaussain C, Imel EA, de Beur SMJ, Florenzano P, Abu Alrob H, Aldabagh R

Journal of Clinical Endocrinology and Metabolism (JCEM)202528 citations

DOI: 10.1210/clinem/dgaf170

Systematic Review: Efficacy of Medical Therapy on Outcomes Important to Adult Patients With X-Linked Hypophosphatemia

Ali DS, Mirza RD, Alsarraf F, Hussein S, Abu Alrob H, Appelman-Dijkstra NM, Beck-Nielsen SS, Biosse-Duplan M, Brandi ML, Carpenter TO

Journal of Clinical Endocrinology and Metabolism (JCEM)202510 citationsOpen Access

DOI: 10.1210/clinem/dgae890 PMID: W4405710358

Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience

Ali DS, Alsarraf F, Abu Alrob H, Alexander RT, Almoulia A, Appelman-Dijkstra NM, Beck-Nielsen SS, Biosse-Duplan M, Brandi ML, Carpenter TO

Journal of Clinical Endocrinology and Metabolism (JCEM)20253 citations

DOI: 10.1210/clinem/dgaf180

Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adults

Ali DS, Khan AA, Mirza RD, Appelman-Dijkstra NM, Brandi ML, Carpenter TO, Chaussain C, Imel EA, de Beur SMJ, Florenzano P

Journal of Bone and Mineral Metabolism20253 citations

DOI: 10.1007/s00774-025-01585-z

Wilms' tumor gene 1: lessons from the interface between kidney development and cancer.

Torban E, Goodyer P

American journal of physiology. Renal physiology2024Senior author

DOI: 10.1152/ajprenal.00248.2023 PMID: 37916284

Something wrong or missing on this profile? Suggest a correction

Paul Goodyer

Research

Latest papers

Latest funding

Clinical practice recommendations for the diagnosis and management of nephropathic cystinosis.

Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease

Emerging therapeutic strategies for cystinosis.

Bridging pediatric and adult IgAN: challenges in applying proteinuria-driven recommendations in the new IPNA guidelines.

X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline

X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline

Systematic Review: Efficacy of Medical Therapy on Outcomes Important to Adult Patients With X-Linked Hypophosphatemia

Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience

Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adults

Wilms' tumor gene 1: lessons from the interface between kidney development and cancer.

The 12th International Podocyte Conference, May 30-June 2, 2018

Interactions between host and viral genes in the pathogenesis of nephrotic syndrome

Novel Therapies for Cystinosis

Renal progenitor cells in kidney development and the response to renal injury.

Congenital nephron deficit and essential hypertension.

Developmental genetic determinants of chronic kidney disease.

Frequent collaborators

Elena Torban

Claudia Gagnon

Reza Donald Mirza

Gordon Guyatt

Aliya Khan

Sarah Khan

Thomas Kitzler

Yojiro Yamanaka

Marylise Boutros

John Mitchell

Mallory Downie

ALEXANDRA CAMBIER

Louise Moist

Jerry Pelletier

Mathieu Lemaire

Maxime Bouchard

Matthew Lanktree

Rima Rozen

York Pei

Nada Jabado

Ines Colmegna